Study details
Enrolling now
Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
Anna Stanhewicz, PhD
NCT IDNCT05946798ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
40
Study length
about 4.8 years
Ages
18–50
Sex
Female only
Locations
1 site in IA
What this study is about
This trial is testing whether NADPH oxidase plays a role in microvascular dysfunction after gestational diabetes. Researchers will be looking at how oxidative stress affects blood vessels in women who have had gestational diabetes. It involves injecting Acetylcholine and Insulin aspart into participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Insulin aspart
- 2.Take Acetylcholine
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IV
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
acetylcholine, insulin aspart
Drug routes
injection
Body systems
Reproductive Health